Dr. Patrik Pipkorn, MD

Dr. Pipkorn practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Pipkorn's NPI, 1437565819, was assigned on July 7, 2014. Dr. Pipkorn holds Missouri license 2018015451.

Dr. Pipkorn's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Pipkorn also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Pipkorn's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Pipkorn is also affiliated with Christian Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Pipkorn to 3 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pipkorn practices, 8 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Pipkorn's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Pipkorn is licensed in Missouri.

CMS data shows 749 Medicare services from Dr. Pipkorn across 9 procedure codes in 2024, for 348 Medicare patients. Medicare paid $149,516 for them.

CMS counts 348 Medicare patients who saw Dr. Pipkorn in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pipkorn's median patient age at 70, with 43% women.

In 2024, Dr. Pipkorn wrote 324 Medicare Part D claims for 109 patients. 99% of them were for generic drugs. CMS names the drug for 243 of them, across 9 drugs with 11 or more claims each, at $2,386 in total drug cost. In 2023, CMS named 174 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Pipkorn for performance year 2024, reported as part of a group. Dr. Pipkorn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of melanoma (skin cancer) excision by Dr. Pipkorn, more than 70% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 127 papers to Dr. Pipkorn, published from 2016 to 2025. 2021 was the busiest year, with 26. The most frequent topics are Head and Neck Neoplasms, Free Tissue Flaps and Plastic Surgery Procedures. Dr. Pipkorn has published most often in Otolaryngol Head Neck Surg. Dr. Pipkorn's most frequent co-authors are Ryan Scott Jackson, MD, Joseph Zenga, MD and Jason Thomas Rich, MD.

Dmand AI links Dr. Pipkorn to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell.

CMS Open Payments shows 25 general payments to Dr. Pipkorn from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Baxter Healthcare paid the most, $333.